Clinical pharmacology of atovaquone and proguanil hydrochloride

Journal of Travel Medicine

Volumn 6, Issue SUPPL. 1, 1999, Pages

  Beerahee, Misba ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CYCLOGUANIL; METOCLOPRAMIDE; PROGUANIL; RIFAMPICIN;

ANTIMALARIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; HUMAN; MALARIA; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME ACTIVATION; HUMANS; INTESTINAL ABSORPTION; INTESTINES; LYMPHOCYTES; MALARIA; MALARIA, FALCIPARUM; MALARIA, VIVAX; PROGUANIL;

EID: 0033047352     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Glaxo Wellcome, data on file.
2. Rolan PE, Mercer AJ, Weatherley BC, et al. Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 1994; 17: 13-20.
3. Maegraith BG, Tottey MM, Adams ARD, et al. The absorption and excretion of proguanil and its metabolites in healthy subjects. Ann Trop Med Parasitol 1946; 40:493-506.
4. Wattanagoon Y, Taylor RB, Moody RR, et al. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol 1987; 24:775-780.
5. Hussein Z, Eaves CJ, Hutchmson DB, Canfield CJ. Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br J Clin Pharmacol 1996; 42:589-597.
6. Pudney M, Gutteridge W, Zeman A, et al. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. J Travel Med 1999; 6(Suppl 1):S8-S12.
7. Helsby NA, Edwards G, Breckenridge AM, Ward SA. The multiple dose pharmacokinetics of proguanil. Br J Clin Pharmacol 1993; 35:653-656.
8. Edstein MD, Yeo AE, Kyle DE, et al. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro. Trans R Soc Trop Med 1996; 90:418-421.
9. Shanks GD, Kremsner PG, Sukwa TY, et al. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999; 6(Suppl 1):S21-S27.
10. Edstein MD, Veenendaal JR, Scott HV, Rieckmann KH. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man. Chemotherapy 1988; 34:385-392.
11. Hussein Z, Eaves J, Hutchinson DB, Canfield CJ. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharmacol Ther 1997; 61:518-530.
12. Sukwa TY, Mulenga M, Chisaka N, et al. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg 1999; 60:521-525.
13. Lell B, Luckner D, Ndjave M, et al. Randomised placebo-conrrolled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998; 351:709-713.
14. Sabchareon A, Attanath P, Phanuaksook P, et al. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrugresistant Plasmodium falciparum malaria. Trans R Soc Trop Med 1998; 92:201-206.
15. Sadler BM, Caldwell P, Scott JD, et al. Drug interaction between rifampin and atovaquone (MEPRON) in HIV+ asymptomatic volunteers. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy 1995, San Francisco, CA: 7 (poster A34).
16. ss) and the use of various concomitant medications in AIDS patients with Pneumocystis carinii pneumonia. Sixth International Conference on AIDS 1993, Berlin: 504(abstract no. PO-B531-2213).
17. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB. Malarone (atovaquone and proguanil hydrochloride):a review of its clinical development for treatment of malaria. Am J Trop Med Hyg 1999; 60:533-541.
18. Anabwani G, Canfield CJ, Hutchinson DBA. Combination atovaquone and proguanil hydrochloride versus halofantrine for treatment of acute Plasmodium falciparum malaria in children. Pediatr Infect Dis J 1999; 18:456-461.
19. Looareesuwan S, Viravan C, Webster HK, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54:62-66.